Mesenchymal–epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas
Shaowei Li(Uniformed Services University of the Health Sciences), Thomas N. Darling(National Institutes of Health), Joel Moss(National Institutes of Health), Jianwu Wang(South China Agricultural University), Gustavo Pacheco–Rodriguez(National Institutes of Health), Toshi Komurasaki(Taisho Pharmaceutical (Japan)), Eric M. Billings(National Institutes of Health), Qingyuan Fan(Cleveland Clinic), Fumiko Takeuchi(Uniformed Services University of the Health Sciences)
Cited by 56
Related Papers
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
The NHLBI Lymphangioleiomyomatosis Registry
|American Journal of Respiratory and Critical Care Medicine|2005|479
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
|American Journal of Respiratory and Critical Care Medicine|2016|366
Molecules in the ARF Orbit
|Journal of Biological Chemistry|1998|343
Epiregulin
|Journal of Biological Chemistry|1995|267